Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study-Reference-Cited by-同舟云学术

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

Published:2014-03 Issue:3 Volume:25 Page:611-618
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Dieci M.V.,Criscitiello C.,Goubar A.,Viale G.,Conte P.,Guarneri V.,Ficarra G.,Mathieu M.C.,Delaloge S.,Curigliano G.,Andre F.

Funder

TRANSCAN JCT-2011

French NCI

Monica Boscolo 2012

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/25/3/611/16698912/mdt556.pdf

Reference12 articles.

1. Pathological complete response and accelerated drug approval in early breast cancer;Prowell;N Engl J Med,2012

2. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy;Apetoh;Nat Med,2007

3. Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer;André;Clin Cancer Res,2013

4. Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy;Demaria;Clin Cancer Res,2001

5. In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival;Ladoire;J Pathol,2011

Cited by 351 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-Infiltrating Lymphocyte Scoring in Neoadjuvant-Treated Breast Cancer;Cancers;2024-08-20

2. Association of tumor-infiltrating lymphocytes with clinical outcomes in patients with triple-negative breast cancer receiving neoadjuvant chemotherapy: a systematic review and meta-analysis;Clinical and Translational Oncology;2024-08-18

3. A review concerning the breast cancer-related tumour microenvironment;Critical Reviews in Oncology/Hematology;2024-07

4. On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer;2024-06-26

5. Peroxiporins in Triple-Negative Breast Cancer: Biomarker Potential and Therapeutic Perspectives;International Journal of Molecular Sciences;2024-06-17